Overview


According to FutureWise analysis the market for gene sequencing in 2023 is US$ 10.77 billion, and is expected to reach US$ 49.24 billion by 2031 at a CAGR of 20.92%.

Scientists now have the ability to quickly develop Gene Sequencing technology, which allows them to produce information on genetic variation and outline gene expression at an unprecedented scale. Scientists will soon be able to sequence whole human genomes using the Gene Sequencing technology in just a few years. Scientists and clinicians will be able to use this technology as a standard tool. Many sequencing platforms are currently in development and have the potential for greater resolution and throughput. Massively parallel sequencing technologies are currently changing almost every field of genetics. Pharmacogenomics is no exception. The detection of new genetic variations that could influence drug response is the most important application of the latest sequencing technologies in the field. With a 43.3% revenue share in 2019, consumables dominated Gene Sequencing. A larger market share is due to the wide range of kits and reagents available to support all stages of library construction (DNA fragmentation, enrichment and adapter ligation), as well as quality control and quality control. These tools have streamlined workflows and are compatible with low-input specimens and formalin-fixed specimens. Sequencing by synthesis, sequencing by ion semiconductor, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination sequencing, and nanopore sequencing are some of the technology platforms that fall under this category. Based on product type, sequencing by synthesis is the most popular platform for gene sequencing and the largest contributor to Gene Sequencing market. This market is expected to see the fastest growth during the forecast period. Gene Sequencing finds applications in biomarker, cancer, diagnostics and personalized medicine. Modern technological advances have greatly improved the speed of sequencing and reduced both the cost and number of protocol steps. These factors have made Gene Sequencing technology the preferred choice for studying biomarkers. Because of the advancement in technology, the Gene Sequencing market offers tremendous opportunities for new players. The key players are now exploring new opportunities and leveraging their technological advances. Market players have the opportunity to expand in the future with the advent of next-generation Gene Sequencing (NGS).

FutureWise Market Research has instantiated a report that provides an intricate analysis of Gene Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Gene Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Agilent Tecnologies Inc
  • Thermo Fisher Scientific Inc
  • Illumina
  • Pacific Biosciences of California Inc
  • Qiagen
  • F.Hoffmann-La Roche Ltd
  • Myriad Genetics
  • PierianDx
  • Eurofins Scientific
  • Intrexon Bioinformatics Germany GmbH

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Consumables
  • Instruments
  • Services

By Application

  • Oncology, Reproductive Health
  • Clinical Investigation
  • Consumer Genomics
  • Metagenomics
  • Others

By Workflow Type

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

By End-User

  • Academic Research
  • Clinical research
  • Hospitals
  • Pharmaceutical Companies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Gene Sequencing Market By Product Type, By Application, By Workflow Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Gene Sequencing Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Gene Sequencing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Gene Sequencing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Gene Sequencing Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Consumables
        2. Instruments
        3. Services

  • 8.   Gene Sequencing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oncology, Reproductive Health
        2. Clinical Investigation
        3. Consumer Genomics
        4. Metagenomics
        5. Others

  • 9.   Gene Sequencing Market, By Workflow Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pre-Sequencing
        2. Sequencing
        3. Data Analysis

  • 10.   Gene Sequencing Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic Research
        2. Clinical research
        3. Hospitals
        4. Pharmaceutical Companies
        5. Others

  • 11.   North America Gene Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Gene Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Gene Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Gene Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Agilent Tecnologies Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Illumina
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pacific Biosciences of California Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Qiagen
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. F.Hoffmann-La Roche Ltd
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Myriad Genetics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PierianDx
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Eurofins Scientific
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. Intrexon Bioinformatics Germany GmbH
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients